| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPENDO.1984.247.2.E198 |
| P953 | full work available at URL | https://www.physiology.org/doi/pdf/10.1152/ajpendo.1984.247.2.E198 |
| P698 | PubMed publication ID | 6147094 |
| P2093 | author name string | P. E. Cryer | |
| T. F. Tse | |||
| S. D. Shah | |||
| W. E. Clutter | |||
| P2860 | cites work | The adrenomedullary and glucagon responses of hypopituitary children to insulin-induced hypoglycemia | Q72896212 |
| Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects | Q33821879 | ||
| Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion | Q33821886 | ||
| Neural control of counter-regulatory events during glucopenia in man. | Q34508674 | ||
| Glucagon response to hypoglycemia in sympathectomized man | Q35197978 | ||
| The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man | Q35902201 | ||
| Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus | Q37007413 | ||
| Adrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man | Q37021401 | ||
| Epinephrine-induced insulin resistance in man. | Q37021517 | ||
| Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. | Q37023863 | ||
| Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon | Q37031053 | ||
| Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia | Q37034985 | ||
| Influence of Continuous Physiologic Hyperinsulinemia on Glucose Kinetics and Counterregulatory Hormones in Normal and Diabetic Humans | Q37038049 | ||
| Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia | Q37039189 | ||
| The Control of Glycogen Metabolism in the Liver | Q37116559 | ||
| Glucose Counterregulation in Man | Q40083853 | ||
| Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones | Q41210907 | ||
| Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man | Q41452468 | ||
| Persistent effect of sustained hyperglucagonemia on glucose production in man | Q41500190 | ||
| Blood Glucose Regulates the Effects of Insulin and Counterregulatory Hormones on Glucose Production In Vivo | Q41624307 | ||
| Evaluation of the control of glucagon secretion by the parasympathetic nervous system in man | Q41642821 | ||
| Plasma catecholamines during paroxysmal neurogenic hypertension in quadriplegic man | Q43561256 | ||
| Homeostasis during hypoglycemia: central control of adrenal secretion and peripheral control of feeding | Q48303037 | ||
| Effect of mannose, fructose and hydroxybutyrate on the hepatic response to hypoglycemia | Q48745070 | ||
| Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. | Q51654836 | ||
| Adrenergic mechanisms in the metabolic adaptation to fasting and feeding: effects of phlorizin on diet-induced changes in sympathoadrenal activity in the rat. | Q51657391 | ||
| Initial splanchnic extraction of ingested glucose in normal man. | Q52792774 | ||
| Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. | Q54340182 | ||
| Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. | Q55062500 | ||
| Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion | Q66904722 | ||
| Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man | Q67550210 | ||
| Glucose uptake and production during the oral glucose tolerance test | Q69848064 | ||
| Rdevance of Glucose Counterregulatory Systems to Patients with Diabetes: Critical Roles of Glucagon and Epinephrine | Q70250273 | ||
| Selective counterregulatory hormone responses after oral glucose in man | Q70429927 | ||
| In vivo deactivation of peripheral, hepatic, and pancreatic insulin action in man | Q71470102 | ||
| Epinephrine, norepinephrine, glucagon, and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man | Q72152947 | ||
| Physiologic Effects of Epinephrine on Glucose Turnover and Plasma Free Fatty Acid Concentrations Mediated Independently of Glucagon | Q72439831 | ||
| Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog | Q72456648 | ||
| Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man | Q72487422 | ||
| P433 | issue | 2 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | physiology | Q521 |
| epinephrine | Q28163586 | ||
| glucagon | Q28163629 | ||
| P304 | page(s) | E198-205 | |
| P577 | publication date | 1984-08-01 | |
| P1433 | published in | American Journal of Physiology | Q2160146 |
| P1476 | title | Roles of glucagon and epinephrine in hypoglycemic and nonhypoglycemic glucose counterregulation in humans | |
| P478 | volume | 247 |
| Q51651099 | Adrenocorticotrophic hormone, cortisol and catecholamine concentrations during insulin hypoglycaemia in dogs anaesthetized with thiopentone. |
| Q36455925 | Epinephrine deficiency results in intact glucose counter-regulation, severe hepatic steatosis and possible defective autophagy in fasting mice |
| Q44030234 | Epinephrine effects on insulin-glucose dynamics: the labeled IVGTT two-compartment minimal model approach |
| Q34519321 | Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion |
| Q33909644 | Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits |
| Q34360096 | Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs |
| Q48000380 | Investigating the impact of overnight fasting on intrinsic functional connectivity: a double-blind fMRI study |
| Q39561130 | Pathophysiology of sympathoadrenal system |
| Q43512318 | Reference intervals for glucose, beta-cell polypeptides, and counterregulatory factors during prolonged fasting |
| Q36228987 | The cat as a model for human obesity and diabetes |
| Q40884510 | alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice |
Search more.